Loratadine Switch Profitable For Payers, Consumers – Study
This article was originally published in The Tan Sheet
Executive Summary
The Rx-to-OTC switch of loratadine has resulted in a decrease in prescription antihistamine use and cost, a study published in the June American Journal of Managed Care finds